An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis | MicrobiomeTrials
An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-06-29Est. Completion: 2027-07-31
Enrollment target: 25 participants
Locations
Erick H. Alayo Medical Corporation - Gastro SB Clinic, Chula Vista, California, United States
Allied Biomedical Research Institute, Inc, Miami, Florida, United States
Gastro Health Research, Miami, Florida, United States
Charite Research Organisation GmbH, Berlin, Germany
Royal Liverpool University Hospital, Liverpool, United Kingdom
University College London Hospitals, London, United Kingdom
Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom